RG

Rukhmani Goyal

Active Director Director DIN 00257393
DIN 00257393 First appointment Jun 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2004
Shareholding value •••• Premium profile

About Rukhmani Goyal

Data last updated:

Rukhmani Goyal is a Director at Garle Impex Private Limited (since 2004). The company operates in Pharma. Garle Impex Private Limited reported revenue of ₹6.67 Cr (FY 2025).

DIN 00257393
Primary Designation Director
Industry Pharma
First Appointment 11 Jun 2004
Oldest Company Age 22 yrs
Largest company Garle Impex Private Limited · ₹6.67 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Garle Impex Private Limited U52206MP2004PTC016691
Director11 Jun 20042004₹6.67 Cr (FY 2025)Active

Board colleagues of Rukhmani Goyal

NameDINCompanyDesignation
Raj Kumar Goyal00257397Garle Impex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Garle Impex Private Limited
Premium access

Shareholding and investment profile for Rukhmani Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rukhmani Goyal

Rukhmani Goyal currently holds 1 directorship: Garle Impex Private Limited (Director, since 11 Jun 2004, revenue ₹6.67 Cr (FY 2025)).

Rukhmani Goyal was first appointed on 11 Jun 2004 as Director at Garle Impex Private Limited.

The current boards of Rukhmani Goyal's companies include Raj Kumar Goyal (Garle Impex Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available